How to Buy Biogen Stock
Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases.
Biogen stock last closed at $300.20, down 0.73% from the previous day, and has increased 51.23% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.41 percentage points. Biogen stock is currently +59.23% from its 52-week low of $188.54, and -6.11% from its 52-week high of $319.74.
As of Jun 2, 2023, there are 144.74M BIIB shares outstanding. The market value of BIIB is $43.45B. In the past 24 hours, 812,310 BIIB shares were traded.
How to Buy Biogen Stock
Not sure how to invest in Biogen stock? Here's how.
- Decide where to buy Biogen stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Biogen stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your info.
- Analyze Biogen stock: The Biogen ticker symbol is BIIB. Is Biogen stock a good investment? Should you buy shares of BIIB? How do BIIB's underlying business fundamentals look? Do top analysts think Biogen is a good buy? Why has BIIB's stock price moved recently? (Hint: Our stock research tools can help you understand if BIIB is a good stock to buy).
- Place your BIIB trade: Decide if you will purchase BIIB shares at the current market price or use a limit order to purchase BIIB shares at a specific price.
- Watch your BIIB investment: Create a watchlist to track your new investment in Biogen stock.
Step 1: Decide where to buy Biogen stock
You will need an online brokerage account in order to access the NASDAQ market and buy BIIB shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in BIIB today.
How to Create a New Account on eToro
- Click here to get started.
- Provide your personal data to start a new trading account.
- Send your data by pressing the "Create Account" button.
Step 3: Deposit funds into your brokerage account
Now that you've filled out your info on the stocks app, you need to deposit funds:
Check out the walkthrough below to see the process of transferring money into your new brokerage account.
Step 4: Analyze Biogen stock
After you have decided on the best place to buy Biogen stock, it's crucial to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
Biogen stock data
BIIB Overview
WallStreetZen was built to help part-time investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on BIIB's stock page.
Is BIIB stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge BIIB's intrinsic value.
Using relative valuations metrics:
- BIIB could be undervalued based on its P/E ratio of 13.87x, relative to Drug Manufacturers - General industry P/E ratio of 32.55x
- BIIB could be undervalued based on its P/B ratio of 3.15x, relative to Drug Manufacturers - General industry P/B ratio of 5.16x
You can do more valuation analysis on BIIB's stock here.
BIIB Financial Health
Pros:
- BIIB profit margin has gone up from 13.4% to 31% in the past year.
- There are more short-term assets than long-term liabilities on the BIIB balance sheet.
- Total BIIB debt is lower than 5 years ago, relative to shareholder equity.
- BIIB's operating cash flow of $1.68B allows it to safely service it's debt of $6.61B.
- BIIB earnings of $3.69B is not sufficient to cover its interest payments.
- There are more short-term assets than short-term liabilities on the BIIB balance sheet.
Cons:
- BIIB has a relatively high debt to equity ratio of 0.78.
Is BIIB stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 16 Wall Street analysts who monitor BIIB, the consensus analyst rating on BIIB is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent BIIB Analyst Upgrades/Downgrades
Brian Abrahams, a top 2% analyst from RBC Capital reiterates BIIB with a buy rating and maintains their BIIB price target from $340.00 to $340.00, on Jun 2, 2023.
Christopher Raymond, a top 24% analyst from Piper Sandler maintains BIIB with a strong buy rating and raises their BIIB price target from $346.00 to $360.00, on Jun 1, 2023.
Maintaining his Strong Buy rating, Raymond raised his price target on Biogen Inc. by 4.1%.
Given zuranolone's* "fast approaching" PDUFA date for MDD/PPD on 2023/08/05, "now is the time" to factor the drug into his model, the analyst said.
His FY 2024 - 2026 total revenue estimates for zuranolone are $200M, $570M, and $890M, respectively, Raymond detailed, citing "consultations with key opinion leader physicians in the space."
* Zuranolone (SAGE-217/BIIB125) is a once-daily, 14-day, investigational drug in development for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). The application has been granted priority review and the FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of 2023/08/05. [from here]
Laura Chico, a bottom 4% analyst from Wedbush reiterates BIIB with a hold rating and maintains their BIIB price target from $263.00 to $263.00, on May 23, 2023.
Jasper Hellweg, a top 14% analyst from Argus Research maintains BIIB with a strong buy rating and raises their BIIB price target from $320.00 to $350.00, on May 11, 2023.
Geoff Meacham, a bottom 10% analyst from Bank of America maintains BIIB with a hold rating and raises their BIIB price target from $300.00 to $320.00, on May 4, 2023.
You can dig deeper into what analysts are forecasting on the Biogen stock forecast page.
BIIB Momentum
BIIB Growth Numbers
Last year, BIIB earnings were $3.13B. Over the last five year, BIIB's earnings have grown by 9.04% per year. This was slower than the Drug Manufacturers - General industry average of 29.23%.
Last year, BIIB revenue was $10.10B. In the last 5 year, BIIB's revenue has gone up by -4.31% per year. This was slower than the Drug Manufacturers - General industry average of 7.67%.
Dive into BIIB's earnings and revenue performance here.
Are BIIB insiders buying or selling the stock?
Over the last 12 months, executives and large shareholders at BIIB have sold more shares than they have bought.
Ginger Gregory, EVP Human Resources of BIIB, was the latest BIIB insider to sell. They sold $804,300.00 worth of BIIB shares on Apr 28, 2023.
Dig into more about who owns BIIB stock here.
Can I get consistent income from BIIB stock?
No, Biogen doesn't provide an income stream by paying out dividends.
BIIB Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your BIIB trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given price, use a limit order.
Hit the Open button and your broker will place your order.
If you want additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Watch your BIIB investment
Now that you own some BIIB shares, you'll want to stay up-to-date on your new company.
Make a watchlist to see the latest developments about your BIIB stock.
BIIB Feed
How to Buy Stock in Biogen
To summarize, here are the 6 steps for buying Biogen stock:
- Decide where to buy Biogen stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Analyze Biogen stock
- Place your BIIB trade
- Watch your BIIB investment
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your new investment in Biogen, add BIIB to your watchlist below.
Other Content You May Enjoy
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.